Showing results (2111-2120 of 6,739) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|April 20, 2018
Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathwayLei Zheng, Huanhuan Zhou, Liwei Guo, et al.
Oncotargets and Therapy|April 20, 2018
Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathwayMing Sun, Zhaofu Chen, Shutao Tan, et al.
Oncotargets and Therapy|April 20, 2018
Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapyGang Wang, Wen-Ling Wang, Yi-Qun Liu, et al.
Oncotargets and Therapy|April 20, 2018
Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three casesYuan Cheng, Juan Zhang, Haiyun Geng, et al.
Oncotargets and Therapy|April 20, 2018
Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombusCheng Peng, Liangyou Gu, Lei Wang, et al.
Oncotargets and Therapy|April 20, 2018
Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitinationYuanfeng Zhou, Kuifeng Wang, Ni Zhou, et al.
Oncotargets and Therapy|October 6, 2021
Identification of a Novel SLC8A1-ALK Fusion and Non-Canonical Expression Significantly Responding to ALK-TKIs in Lung Adenocarcinoma: A Case ReportXingyu Zhu, Yuqi He, Yin Wang, et al.
Oncotargets and Therapy|October 8, 2021
LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation [Retraction]
Oncotargets and Therapy|October 28, 2021
A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver CancerMingyi Ju, Longyang Jiang, Qian Wei, et al.
Oncotargets and Therapy|October 28, 2021
Clinical Application of Tumor Vascular Disrupting Therapy: A Systematic Review and Meta-AnalysisWen Tsang, Lu Gan, Zhikun Zhang, et al.
Pageof 674